Latest news
Take-Two’s (NASDAQ:TTWO) Q2 CY2026 Sales Beat Estimates But Full-Year Sales Guidance Misses Expectations Significantly - StockStoryStockStory · Fri, 07 Aug 2026 14:48:38 GMTPPL Misses Q2 Expectations but Reaffirms Full-Year Outlook - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:50:44 GMT10x Genomics’s (NASDAQ:TXG) Q2 CY2026: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations - TradingViewTradingView · Thu, 06 Aug 2026 21:45:12 GMTHealth Catalyst (NASDAQ:HCAT) Exceeds Q2 CY2026 Expectations But Stock Drops 25.5% - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 21:01:00 GMTVerra Mobility (NASDAQ:VRRM) Beats Q2 CY2026 Sales Expectations But Stock Drops 14.6% - StockStoryStockStory · Wed, 05 Aug 2026 21:29:44 GMTInter Parfums (NASDAQ:IPAR) Posts Better-Than-Expected Sales In Q2 CY2026 But Full-Year Sales Guidance Misses Expectations - Yahoo Finance AustraliaYahoo Finance Australia · Tue, 04 Aug 2026 21:27:46 GMTAlight (NYSE:ALIT) Beats Q2 CY2026 Sales Expectations But Stock Drops On Weak Guidance - The Chronicle-JournalThe Chronicle-Journal · Tue, 04 Aug 2026 20:54:00 GMTBRBR: Q3 sales beat expectations, but margins fell; price hikes and cost cuts planned for 2027 recovery - TradingViewTradingView · Tue, 04 Aug 2026 14:47:16 GMT